|
Mechanismβ1-adrenergic receptor antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.Japan |
First Approval Date05 Jul 2002 |
100 Clinical Results associated with AOP Health US LLC
0 Patents (Medical) associated with AOP Health US LLC
100 Deals associated with AOP Health US LLC
100 Translational Medicine associated with AOP Health US LLC